SPL-108
Oncology & Arthritis
Phase 2Active
Key Facts
About Splash Pharmaceuticals
Splash Pharmaceuticals is a private, clinical-stage biotech based in San Diego, founded in 2015, with a focus on targeting CD44 for cancer and arthritis. Its lead asset, SPL-108, has generated promising safety and efficacy data across multiple trials, positioning the company for potential partnerships. The firm operates as a pre-revenue therapeutics developer seeking collaboration to advance its programs.
View full company profile